????? ?? ?? ? ??? ????????????? ????????????????? ???????????????????gene in patients relapsing after cure Together with the BCL2 antagonist venetoclax. sixty six Resistance to those brokers has actually been connected with these mutations in all over 70% of situations, Despite the fact that they are often subclonal and their particular job produci